In Brief: Hoffmann-La Roche
Executive Summary
Hoffmann-La Roche: Alan Bess, MD, to VP-drug safety, succeeding James LaBraico, MD, who recently retired. Bess was previously director of drug safety...
Hoffmann-La Roche: Alan Bess, MD, to VP-drug safety, succeeding James LaBraico, MD, who recently retired. Bess was previously director of drug safety.... |